Haleon Starts Standalone Life By Raising Sales Expectations
A better than expected first-half performance has put Haleon on a sure footing for the rest of the year following its recent demerger from GSK.
You may also be interested in...
The global market leader in consumer health is now Haleon following its separation from GSK after more than two years of planning.
Major Europe-based consumer health players Bayer, Sanofi, Reckitt and GSK feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q2 2022 results over the coming weeks.
GSK Consumer Healthcare's CEO Brian McNamara said he had not seen signs that the cost of living crisis was impacting consumer purchases, with sales at the business up 16% in Q1.